• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Dominari Holdings Inc. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits

    4/30/25 5:15:08 PM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $DOMH alert in real time by email
    false 0000012239 0000012239 2025-04-25 2025-04-25 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

    Pursuant to Section 13 or Section 15(d)

    of the Securities Exchange Act of 1934

     

    Date of Report (Date of earliest event reported): April 25, 2025

     

    Dominari Holdings Inc.

    (Exact name of registrant as specified in its charter)

     

    Delaware   001-41845   52-0849320

    (State or other jurisdiction

    of incorporation)

      (Commission File Number)  

    (IRS Employer

    Identification No.)

     

    725 5th Avenue, 22nd Floor

    New York, NY 10022

    (212) 393-4540

    (Address, including Zip Code and Telephone Number, including

    Area Code, of Principal Executive Offices)

     

    Not Applicable

    (Former name or former address, if changed since last report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation to the registrant under any of the following provisions:

     

    ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading Symbol(s)   Name of each exchange on which registered
    Common Stock, $0.0001 par value   DOMH   The Nasdaq Capital Market

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company ☐

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     

     

     

    Item 4.01 Changes in Registrant’s Certifying Accountant.

     

    On November 1, 2024, CBIZ CPAs P.C. acquired the attest business of Marcum LLP (“Marcum”) which was engaged as the independent registered public accounting firm of Dominari Holdings Inc. (the “Company”). As a result of this transaction, on April 25, 2025, Marcum resigned as auditor of the Company, and with the approval of the Audit Committee of the Company’s Board of Directors, CBIZ CPAs P.C. was engaged as the Company’s new independent registered public accounting firm for the fiscal year ending December 31, 2025.

     

    The reports of Marcum regarding the Company’s financial statements for the fiscal years ended December 31, 2024 and 2023, did not contain any adverse opinion or disclaimer of opinion and were not qualified or modified as to uncertainty, audit scope, or accounting principles.

     

    During the fiscal years ended December 31, 2024 and 2023, and through April 25, 2025, the date of Marcum’s resignation, there were (a) no disagreements (as defined in Item 304(a)(1)(iv) of Regulation S-K and the related instructions) with Marcum on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedures, which disagreements, if not resolved to the satisfaction of Marcum, would have caused Marcum to make reference to such disagreement in its report and (b) no “reportable events” (as defined in Item 304(a)(1)(v) of Regulation S-K and the related instructions).

     

    During the fiscal years ended December 31, 2024 and 2023, and through April 25, 2025, neither the Company nor anyone on the Company’s behalf consulted with CBIZ CPAs P.C. regarding (i) the application of accounting principles to a specific completed or contemplated transaction or regarding the type of audit opinions that might be rendered by CBIZ CPAs P.C. on the Company’s financial statements, and CBIZ CPAs P.C. did not provide any written or oral advice that was an important factor considered by the Company in reaching a decision as to any such accounting, auditing, or financial reporting issue or (ii) any matter that was either the subject of a disagreement (as defined in Item 304(a)(1)(iv) of Regulation S-K and the related instructions), as that term is described in Item 304(a)(1)(iv) of Regulation S-K, or a reportable event, as that term is defined in Item 304(a)(1)(v) of Regulation S-K.

     

    The Company provided Marcum with a copy of this Current Report on Form 8-K prior to its filing with the U.S. Securities and Exchange Commission (the “SEC”) and requested that Marcum furnish the Company with a letter addressed to the SEC, pursuant to Item 304(a)(3) of Regulation S-K, stating whether it agrees with the above statements and, if it does not agree, the respects in which it does not agree. A copy of the letter, dated April 30, 2025, is filed as Exhibit 16.1 (which is incorporated by reference herein) to this Current Report on Form 8-K.

     

    Item 9.01. Financial Statements and Exhibits.

     

    (d) Exhibits

     

    Exhibit   Description
    16.1   Letter from Marcum, dated April 30, 2025
    104   Cover Page Interactive Data File (formatted as Inline XBRL)

     

    1

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Dated: April 30, 2025 DOMINARI HOLDINGS INC.
         
      By:

    /s/ Anthony Hayes

      Name:  Anthony Hayes
      Title: Chief Executive Officer

     

     

    2

     

    Get the next $DOMH alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $DOMH

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $DOMH
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Dominari Holding's Strategic Interest in Bitcoin Mining Set to Go Public

      American Bitcoin Enters into Definitive Merger Agreement with Nasdaq-listed Gryphon Digital Mining to Build World's Largest, Most Efficient Pure-Play Bitcoin Minor Alongside A Robust and Strategic Bitcoin Reserve NEW YORK, May 13, 2025 /PRNewswire/ -- Dominari Holdings Inc. (NASDAQ:DOMH), today congratulates American Bitcoin on entering into a definitive merger agreement with Gryphon Digital Mining, Inc. (NASDAQ:GRYP). The strategic stock-for-stock transaction will result in American Bitcoin becoming a publicly traded entity on Nasdaq in which former American Bitcoin stockholders, including Dominari Holdings, will own approximately 98% of the combined company.

      5/13/25 8:00:00 AM ET
      $DOMH
      $GRYP
      Biotechnology: Pharmaceutical Preparations
      Health Care
      EDP Services
      Technology
    • authID Announces Pricing of Approximately $8,150,000 Million Registered Direct Offering

      DENVER, March 31, 2025 (GLOBE NEWSWIRE) -- authID Inc. (NASDAQ:AUID) ("authID" or the "Company"), a leading provider of biometric identity verification and authentication solutions, today announced it has entered into a definitive agreement with investors to sell approximately 1,811,111 shares  of its common stock (the "Shares") and/or Pre-Funded Warrants (the "Pre-Funded Warrants"), pursuant to a registered direct offering (the "Registered Direct Offering"). The purchase price for one Share or Pre-Funded Warrant will be $4.50, (each Pre-Funded Warrant will be exercisable into one share of common stock). The aggregate gross proceeds from the Offering are expected to be approximately $8,15

      3/31/25 8:30:00 AM ET
      $AUID
      $DJT
      $DOMH
      $DWAC
      Computer Software: Prepackaged Software
      Technology
      Computer Software: Programming Data Processing
      Biotechnology: Pharmaceutical Preparations
    • Dominari Holdings Investment, American Data Centers, Becomes American Bitcoin in Transformative Bitcoin Mining Deal with Hut 8

      Dominari Executing Expansion Strategy with Investment in Industrial Scale Bitcoin Mining and Bitcoin Reserve Development  NEW YORK, March 31, 2025 /PRNewswire/ -- Dominari Holdings Inc. (NASDAQ:DOMH) today announced that American Data Centers Inc. ("ADC") and Hut 8 Corp, ("Hut") partnered to form American Bitcoin Corporation.  As previously announced, ADC was a wholly owned subsidiary of Dominari, but became an independent company, whose members include Donald J. Trump Jr., Eric Trump, Dominari and other industry professionals in the AI space.  In partnership with Hut, American Bitcoin Corp., will focus on industrial-scale bitcoin mining and strategic bitcoin reserve development and monetiza

      3/31/25 8:00:00 AM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $DOMH
    Leadership Updates

    Live Leadership Updates

    See more
    • Dominari Holdings Inc. Strengthens Team with Appointment of Experienced Accounting Team

      Edward Deignan Appointed as VP of Finance and Accounting Kyle Degruttola Appointed as Controller NEW YORK, NY / ACCESSWIRE / November 11, 2024 / Dominari Holdings Inc. (NASDAQ:DOMH) (the "Company") today announced that it has appointed Edward Deignan as Vice President of Finance and Accounting and Kyle Degruttola as Controller. Together, they bring decades of accounting and finance leadership experience from various multi-national and public sector organizations.Mr. Deignan is responsible for the day-to-day management of the Company's financial operations. He brings with him more than 30 years of experience in accounting, finance and banking. He has served as a chief financial officer for s

      11/11/24 8:00:00 AM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Dominari Securities LLC Announces Appointment of Capital Markets Veteran James Hopkins as Managing Director Head of Capital Markets

      Hopkins has Led and Structured Hundreds of Capital Markets Transactions NEW YORK, NY / ACCESSWIRE / October 7, 2024 / Dominari Holdings Inc. (NASDAQ:DOMH) (the "Company") today noted that its wholly-owned subsidiary, Dominari Securities LLC ("Dominari"), announced that it has further expanded its practice with the appointment of capital markets veteran James (Jimmy) Hopkins as Managing Director Head of Capital Markets.Mr. Kyle Wool, CEO of Dominari Securities LLC, commented, "Our commitment to positioning Dominari as a full-service, diversified financial services firm and growing our business remains stronger than ever, and Jimmy has a proven record of success with hundreds of completed tran

      10/7/24 8:00:00 AM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Dominari Securities Appoints 30 Year Financial Industry Expert to Manage Operations and Compliance

      Eric Newman Appointed as Executive Vice President  NEW YORK, March 15, 2024 /PRNewswire/ -- Dominari Holdings Inc. (NASDAQ:DOMH) (the "Company") today announced its wholly-owned subsidiary, Dominari Securities LLC, has appointed financial industry veteran, Eric Newman, to the role of Executive Vice President of Dominari Securities enriching the firm's investment banking expertise and bolstering its brokerage operations. Mr. Newman reports directly to CEO Kyle Wool and is responsible for managing the day-to-day aspects of the firm's broker-dealer operations, advising executive

      3/15/24 8:30:00 AM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $DOMH
    Financials

    Live finance-specific insights

    See more
    • Dominari Holdings Investment, American Data Centers, Becomes American Bitcoin in Transformative Bitcoin Mining Deal with Hut 8

      Dominari Executing Expansion Strategy with Investment in Industrial Scale Bitcoin Mining and Bitcoin Reserve Development  NEW YORK, March 31, 2025 /PRNewswire/ -- Dominari Holdings Inc. (NASDAQ:DOMH) today announced that American Data Centers Inc. ("ADC") and Hut 8 Corp, ("Hut") partnered to form American Bitcoin Corporation.  As previously announced, ADC was a wholly owned subsidiary of Dominari, but became an independent company, whose members include Donald J. Trump Jr., Eric Trump, Dominari and other industry professionals in the AI space.  In partnership with Hut, American Bitcoin Corp., will focus on industrial-scale bitcoin mining and strategic bitcoin reserve development and monetiza

      3/31/25 8:00:00 AM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Dominari Securities Acquires Broker Team with $700 Million in Assets Under Management

      Firm Announces Five Day In Office Work Week NEW YORK, April 18, 2023 /PRNewswire/ -- Dominari Holdings Inc. (NASDAQ:DOMH) (the "Company") today announced that its wholly-owned subsidiary, Dominari Securities LLC, a FINRA licensed broker-dealer, has added an asset management team that manages over $700 million in client assets to its organization. This is the first significant acquisition since the division officially launched earlier this month after the purchase of the broker-dealer and registered investment adviser divisions of Fieldpoint Private Securities. Kyle Wool, CEO of Dominari Financial Inc. stated, "we are excited to have launched our broker-dealer division and are proudly open fo

      4/18/23 8:00:00 AM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Dominari Financial Inc. Acquires Leading Broker Dealer and Registered Investment Advisor Business

      Acquisition of Fieldpoint Private Securities Accelerates the Growth of the Company's Business with Launch of New Broker-Dealer and RIA Division NEW YORK, March 27, 2023 /PRNewswire/ -- Dominari Financial Inc., the financial services subsidiary of Dominari Holdings Inc., has announced the acquisition of the broker-dealer and registered investment advisor business of Fieldpoint Private Bank and Trust. The acquired business will be the foundation of a new financial services entity that will be known as Dominari Securities LLC. Fieldpoint Private Bank and Trust will continue to operate its Personal Banking and Commercial Banking entities under its name.

      3/27/23 5:35:00 PM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $DOMH
    SEC Filings

    See more
    • Dominari Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Dominari Holdings Inc. (0000012239) (Filer)

      5/13/25 8:15:21 AM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 10-Q filed by Dominari Holdings Inc.

      10-Q - Dominari Holdings Inc. (0000012239) (Filer)

      5/12/25 8:01:29 PM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Dominari Holdings Inc. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits

      8-K - Dominari Holdings Inc. (0000012239) (Filer)

      4/30/25 5:15:08 PM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $DOMH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Ledwick Tim S bought 8,645 shares and was granted 10,000 shares, increasing direct ownership by 145% to 31,471 units (SEC Form 4)

      4 - Dominari Holdings Inc. (0000012239) (Issuer)

      2/12/25 5:03:10 PM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Director Lieberman Ronald J. bought 21,613 shares and was granted 10,000 shares (SEC Form 4)

      4 - Dominari Holdings Inc. (0000012239) (Issuer)

      2/12/25 5:00:46 PM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • President Wool Kyle Michael bought 288,184 shares, increasing direct ownership by 15% to 2,200,769 units (SEC Form 4)

      4 - Dominari Holdings Inc. (0000012239) (Issuer)

      2/12/25 4:58:43 PM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $DOMH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • CEO Hayes Anthony gifted 15,000 shares, decreasing direct ownership by 0.92% to 1,614,566 units (SEC Form 4)

      4 - Dominari Holdings Inc. (0000012239) (Issuer)

      5/6/25 4:15:04 PM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 4 filed by President Wool Kyle Michael

      4 - Dominari Holdings Inc. (0000012239) (Issuer)

      4/16/25 7:55:12 PM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 4 filed by CEO Hayes Anthony

      4 - Dominari Holdings Inc. (0000012239) (Issuer)

      4/16/25 7:54:31 PM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $DOMH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13D/A filed by Dominari Holdings Inc.

      SC 13D/A - Dominari Holdings Inc. (0000012239) (Subject)

      6/13/24 8:56:04 PM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Amendment: SEC Form SC 13D/A filed by Dominari Holdings Inc.

      SC 13D/A - Dominari Holdings Inc. (0000012239) (Subject)

      6/13/24 4:32:07 PM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care